Contact us
Home > Products > Assay Kits > ADA Assay Kits
Options+
Options
Confirm
  • Product types
    0 selected
    Assay Kit (302)
  • Target
    0 selected
    A29L (4)
    Lexatumumab (1)
    Tovetumab (1)
    Mirikizumab (2)
    Mosunetuzumab (1)
    Remtolumab (1)
    Apamistamab (1)
    Magrolimab (1)
    Tirzepatide (1)
    Trastuzumab (2)
    Ascrinvacumab (1)
    Etanercept (1)
    Infliximab (2)
    Oxelumab (1)
    M1R (4)
    Tigatuzumab (1)
    Ipilimumab (2)
    Dilpacimab (1)
    Ocaratuzumab (1)
    Secukinumab (2)
    Emibetuzumab (1)
    Sibrotuzumab (1)
    Zanidatamab (1)
    Cinpanemab (1)
    Rituximab (1)
    Canakinumab (1)
    Dupilumab (3)
    Iscalimab (1)
    H3L (2)
    Faricimab (1)
    Tremelimumab (1)
    Navicixizumab (1)
    Carlumab (1)
    Tibulizumab (1)
    Tocilizumab (3)
    Amatuximab (1)
    Zenocutuzumab (1)
    CD79B (2)
    Natalizumab (2)
    Gevokizumab (1)
    Varlilumab (1)
    E8L (4)
    Nesvacumab (1)
    Zalifrelimab (1)
    Atezolizumab (3)
    Lorvotuzumab (1)
    Vunakizumab (1)
    Lacnotuzumab (1)
    Anetumab (1)
    Clazakizumab (1)
    Ivuxolimab (1)
    Romiplostim (1)
    Basiliximab (1)
    Sotrovimab (1)
    Camidanlumab (1)
    Talacotuzumab (1)
    A35R (4)
    Vanucizumab (1)
    Edrecolomab (1)
    Avelumab (3)
    Tisotumab (1)
    Tiragolumab (2)
    Sacituzumab (1)
    Ontamalimab (1)
    Olokizumab (1)
    Pogalizumab (1)
    Casirivimab (1)
    Daclizumab (1)
    Vibecotamab (1)
    Eculizumab (3)
    Lupartumab (1)
    Rolinsatamab (1)
    Durvalumab (3)
    Imalumab (1)
    Enoblituzumab (1)
    Semorinemab (1)
    Glembatumumab (1)
    Sirukumab (1)
    Tavolimab (1)
    Lirilumab (1)
    Imdevimab (1)
    Ibalizumab (1)
    Bimagrumab (1)
    Denosumab (3)
    Depatuxizumab (1)
    Anifrolumab (1)
    Pacmilimab (1)
    Andecaliximab (1)
    Mirzotamab (1)
    Tilavonemab (1)
    Balstilimab (1)
    Ziltivekimab (1)
    Cergutuzumab (1)
    Codrituzumab (1)
    F/Fusion glycoprotein F0 (3)
    Tregalizumab (1)
    Daratumumab (3)
    Cetuximab (3)
    Losatuxizumab (1)
    Icrucumab (1)
    Nirsevimab (1)
    Farletuzumab (1)
    Omburtamab (1)
    Zagotenemab (1)
    Cetrelimab (1)
    Labetuzumab (1)
    Astegolimab (1)
    Guselkumab (2)
    Zanolimumab (1)
    Ifabotuzumab (1)
    Sarilumab (2)
    Necitumumab (1)
    Ieramilimab (1)
    Palivizumab (3)
    Mirvetuximab (1)
    Frovocimab (1)
    Befovacimab (1)
    Nivolumab (3)
    Pembrolizumab (3)
    Cabiralizumab (1)
    Belantamab (1)
    Elotuzumab (1)
    Eldelumab (1)
    Letolizumab (1)
    Ustekinumab (3)
    Panitumumab (3)
    Mavezelimab (1)
    Suptavumab (1)
    Bevacizumab (3)
    Lodelcizumab (1)
    Concizumab (1)
    Sintilimab (1)
    Emactuzumab (1)
    Teclistamab (1)
    Evolocumab (1)
    Lenzilumab (1)
    Itolizumab (1)
    Omalizumab (2)
    Serclutamab (1)
    Favezelimab (1)
    Suvizumab (1)
    Brolucizumab (1)
    Tezepelumab (1)
    Marstacimab (1)
    Obinutuzumab (2)
    Tislelizumab (1)
    Cixutumumab (1)
    Pasotuxizumab (1)
    Alirocumab (1)
    Namilumab (1)
    Cusatuzumab (1)
    RBD (4)
    Tesidolumab (1)
    Indatuximab (1)
    Foravirumab (1)
    Ranibizumab (3)
    Elezanumab (1)
    Afutuzumab (1)
    Toripalimab (1)
    Dalotuzumab (1)
    Rosopatamab (2)
    RBD (Omicron/BA.5) (3)
    Otilimab (1)
    Vorsetuzumab (1)
    RBD (Delta) (2)
    Tanezumab (1)
    Lintuzumab (1)
    Rafivirumab (1)
    Varisacumab (1)
    Enfortumab (1)
    Ianalumab (1)
    Epcoritamab (1)
    Afasevikumab (1)
    Figitumumab (1)
    Tarextumab (1)
    dsDNA (1)
    Milatuzumab (1)
    Meplazumab (1)
    Spike glycoprotein (9)
    Adalimumab (3)
    Oleclumab (1)
    Tosatoxumab (1)
    Benufutamab (1)
    Crizanlizumab (1)
    Inclacumab (1)
    Blosozumab (1)
    Glofitamab (1)
    Bimekizumab (1)
    Ganitumab (1)
    Urelumab (1)
    Glycoprotein (4)
    Disitamab (1)
    Alacizumab (1)
    Spike Protein (Trimer) (2)
    Certolizumab (2)
    Zampilimab (1)
    Obiltoxaximab (1)
    Conatumumab (1)
    Olaratumab (1)
    Romosozumab (1)
    Ibritumomab (1)
    Ixekizumab (1)
    Teprotumumab (1)
    Utomilumab (1)
    GP/Envelope glycoprotein (3)
    Pertuzumab (3)
    Ramucirumab (1)
    NP/Nucleocapsid (3)
    Golimumab (2)
    Vofatamab (1)
    Gremubamab (1)
    Drozitumab (1)
  • Applications
    0 selected
    ELISA (302)

Quick access

Contact us

  • +33(0)3 90 20 54 70

  • info@abinscience.com

  • 19 rue de la Haye 67300 Schiltigheim France

Copyright © 2025 Abinscience. All Rights Reserved. All Products are for Research Use Only